FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations. - Wikidata - awgldk - TriplyDB

FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations.

FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations.

http://www.wikidata.org/entity/Q35000851

about

Advancement in treatment and diagnosis of pancreatic cancer with radiopharmaceuticals Utility of PET/CT in diagnosis, staging, assessment of resectability and metabolic response of pancreatic cancer Challenges of Pancreatic Cancer.Applying PET to broaden the diagnostic utility of the clinically validated CA19.9 serum biomarker for oncology.Consistent surgeon evaluations of three-dimensional rendering of PET/CT scans of the abdomen of a patient with a ductal pancreatic mass.Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer.[18F]Fluorodeoxyglucose accumulation as a biological marker of hypoxic status but not glucose transport ability in gastric cancer.Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma.Multiparametric FDG-PET/MRI of Hepatocellular Carcinoma: Initial Experience

P2860

Q26766690-6E0588D9-B403-44AB-BCEF-A1F02BCCC324 Q26827392-D8EB39B8-2748-484B-B832-423D1776E8A9 Q28080671-0CF0E65D-3CFE-4CBC-9A45-BC7A93A542BB Q34762185-F01AA69E-03F1-4179-B4AD-3B4EC3EBFFED Q35005463-AE30F60E-0064-4D8D-AFB5-EF591B9EA675 Q36435260-51EB472D-EE4C-4B7D-ABB9-0D077E59BD21 Q36901233-E111BFF6-9E0A-4AB3-8B0C-17F6BC548157 Q37180312-DD9EE413-79A6-4D19-9F34-4AFA661A1E44 Q46876969-2B589533-6A87-42FD-8FBD-6837BF5560A1 Q58584963-D6732259-DB14-4F62-A4E0-C8B7A44EE2C4

P2860

FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations.

http://www.wikidata.org/entity/Q35000851

description

2011 nî lūn-bûn

@nan

2011 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations.

@ast

FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations.

@en

type

label

FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations.

@ast

FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations.

@en

prefLabel

FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations.

@ast

FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations.

@en

P1433

Q35000851-320DBFC9-AECE-41A9-9B5E-5F7B7D734C51

P1476

Q35000851-BF099CD2-1DAE-4E80-A7FC-A3E576B10E27

P2093

Q35000851-24CD2599-6C56-4EE8-90E0-650F4C31FF02

P2860

Q35000851-1AC1CDD5-0EA7-40FE-A2F4-8CF741583138

Q35000851-1B0FFD25-F9D2-422A-B23C-4218972B1093

Q35000851-1BDA0280-69C7-4970-82EA-9FCFFCFB46EA

Q35000851-1C93A035-73E6-41C4-AD1C-B16A4766B63B

Q35000851-1CCC0635-7202-4E72-8FFF-F033321177C1

Q35000851-5914ACEF-4F80-40C9-A387-6EEAADEC06AD

Q35000851-7A181D16-5706-44E6-83F7-BDA40844480B

Q35000851-927EC57B-B5A8-4421-BB8C-CC5E974C2E63

Q35000851-B653D8C1-8726-4CD3-BB17-C56B177F6718

Q35000851-CD3D33B6-9512-40BB-A640-5791B9AD56C5

P304

Q35000851-04C419B8-BFFE-4837-B7F2-A07DF46FB0F3

P31

Q35000851-40E278FC-C15D-45E1-B717-F16B54A52FCA

P356

Q35000851-4D7CC8A7-C1AF-4714-AFFB-2EC096FBF6E0

P433

Q35000851-F48171EF-C89D-4A85-B21A-1DB845FA92DE

P478

Q35000851-2A2038B0-5723-4A67-A310-E5BEA716D197

P577

Q35000851-8A5FDA72-249C-4FE3-998B-C723C23FCA8B

P5875

Q35000851-70260EB1-99A2-4CD6-8FE5-D2E3F06BCF95

P698

Q35000851-35589052-50DF-4703-90A3-D2FDD858EE13

P932

Q35000851-865C74F1-164B-4F3A-9489-0D9543601164

P356

P1433

World journal of clinical oncology

P1476

FDG-PET for hepatobiliary and pancreatic cancer: Advances and current limitations.

@en

P2093

Koji Murakami

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors.

Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.

Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study.

Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.

11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.

Differential diagnosis of gallbladder cancer using positron emission tomography with fluorine-18-labeled fluoro-deoxyglucose (FDG-PET).

Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma.

18F-FDG PET in the detection of extrahepatic metastases from hepatocellular carcinoma.

Additional value of FDG-PET/CT in management of "solitary" liver metastases: preliminary results of a prospective multicenter study.

Detection of recurrent pancreatic cancer: comparison of FDG-PET with CT/MRI.

P304

229-236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5306/WJCO.V2.I5.229

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51163856

http://www.w3.org/2001/XMLSchema#string

P698

21611100

http://www.w3.org/2001/XMLSchema#string

P932

3100499

http://www.w3.org/2001/XMLSchema#string